ProQR (PRQR) has released an update.
At ProQR Therapeutics N.V.’s 2024 annual general meeting, shareholders approved key resolutions including the adoption of the 2023 annual accounts, management and supervisory board members’ discharge from liability, and the appointment and re-appointment of board members. Additionally, the authorization for the board to issue and acquire ordinary shares and a change to the board structure were also approved, alongside the appointment of KPMG as the external auditor for 2025.
For further insights into PRQR stock, check out TipRanks’ Stock Analysis page.
